IL161608A0 - Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines - Google Patents

Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines

Info

Publication number
IL161608A0
IL161608A0 IL16160802A IL16160802A IL161608A0 IL 161608 A0 IL161608 A0 IL 161608A0 IL 16160802 A IL16160802 A IL 16160802A IL 16160802 A IL16160802 A IL 16160802A IL 161608 A0 IL161608 A0 IL 161608A0
Authority
IL
Israel
Prior art keywords
aralkoxyadenosines
alkoxyadenosines
synthesis
Prior art date
Application number
IL16160802A
Other languages
English (en)
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of IL161608A0 publication Critical patent/IL161608A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL16160802A 2001-10-25 2002-10-24 Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines IL161608A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33516901P 2001-10-25 2001-10-25
US37572302P 2002-04-26 2002-04-26
PCT/US2002/034313 WO2003035662A1 (fr) 2001-10-25 2002-10-24 Synthese d'adenosines 2-aralcoxy et de 2-alcoxyadenosines

Publications (1)

Publication Number Publication Date
IL161608A0 true IL161608A0 (en) 2004-09-27

Family

ID=26989581

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16160802A IL161608A0 (en) 2001-10-25 2002-10-24 Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines
IL161608A IL161608A (en) 2001-10-25 2004-04-25 Synthesis and therapeutic use of 2-aralkoxyadenosines and 2-alkoxyadenosines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161608A IL161608A (en) 2001-10-25 2004-04-25 Synthesis and therapeutic use of 2-aralkoxyadenosines and 2-alkoxyadenosines

Country Status (13)

Country Link
US (1) US6951932B2 (fr)
EP (1) EP1446413A4 (fr)
JP (1) JP2005511551A (fr)
KR (1) KR20040049001A (fr)
CN (1) CN1608076A (fr)
AU (1) AU2002336668B2 (fr)
BR (1) BR0213557A (fr)
CA (1) CA2465264C (fr)
IL (2) IL161608A0 (fr)
NO (2) NO326625B1 (fr)
NZ (1) NZ532541A (fr)
PL (1) PL369327A1 (fr)
WO (1) WO2003035662A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20070232561A1 (en) * 2006-03-31 2007-10-04 Edward Leung Pharmaceutical compositions for promoting wound healing
CA2700729A1 (fr) 2007-10-19 2009-04-23 The University Of Tokyo Agent therapeutique pour le leucoderme et procede d'acceleration de la pigmentation
WO2009085909A1 (fr) * 2007-12-20 2009-07-09 King Pharmaceuticals Research And Development, Inc. Formes cristallines de 2-[2-(4-chlorophényl)éthoxy]adénosine
JP2020513192A (ja) 2017-03-29 2020-05-07 中国医学科学院基礎医学研究所 低分子ｒｎａ、並びに線維増殖性疾患及び／又は症候群の予防及び／又は治療におけるその応用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) * 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4911896A (fr) 1972-05-15 1974-02-01
JPS4920198A (fr) 1972-06-26 1974-02-22
JPS49124096A (fr) 1973-03-31 1974-11-27
JPS5053393A (fr) 1973-09-18 1975-05-12
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
AU6516494A (en) * 1993-04-15 1994-11-08 New York University Adenosine receptor agonists for the promotion of wound healing

Also Published As

Publication number Publication date
NO326625B1 (no) 2009-01-19
AU2002336668B2 (en) 2008-01-10
US6951932B2 (en) 2005-10-04
NO20083239L (no) 2004-06-23
WO2003035662A1 (fr) 2003-05-01
AU2002336668B8 (en) 2003-05-06
PL369327A1 (en) 2005-04-18
US20030199686A1 (en) 2003-10-23
CA2465264C (fr) 2010-09-07
EP1446413A1 (fr) 2004-08-18
JP2005511551A (ja) 2005-04-28
EP1446413A4 (fr) 2007-10-17
KR20040049001A (ko) 2004-06-10
CN1608076A (zh) 2005-04-20
IL161608A (en) 2010-05-31
BR0213557A (pt) 2004-10-26
NO20042126L (no) 2004-06-23
NZ532541A (en) 2005-09-30
CA2465264A1 (fr) 2003-05-01

Similar Documents

Publication Publication Date Title
AU2002346548A8 (en) Regioisomerically pure oxochlorins and methods of synthesis
IL161969A0 (en) Synthesis and purification of valacyclovir
MXPA03006403A (es) Sintesis de la temozolomida y analogos.
AU2002256108A1 (en) Synthesis and use of glycodendrimer reagents
MXPA03006402A (es) Sintesis de temozolomida y analogos.
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
IL158239A0 (en) Zonisamide intermediate and synthesis
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
PL369327A1 (en) Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines
GB0131119D0 (en) Presentation of tones
TW493722U (en) Improved structure of lampwick
EP1392460A4 (fr) Hydrofluorures d'aminosilanols et leur utilisation
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
AU2002360409A8 (en) Methods and intermediates for the synthesis of azepines
AU2001255708A1 (en) Synthesis and use of thienotriazolodiazepines
HU0104370D0 (en) Honeyed schnaps of oerseg
TW501417U (en) Structure of rope-tying buckle
TW573751U (en) Structure capable of preventing jaming
HK1068351A (en) Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines
GB0125482D0 (en) Uses of (s)-clenbuterol
TW494780U (en) Structure of swimmeret
TW501859U (en) Improvement of fixing-stand structure
TW520773U (en) Improved structure of expansion-slot bottom-plate
TW499920U (en) Improved structure of hoverbed
TW567750U (en) Improved structure of panty-hose